Qing Li Peptide
Finnrick has tested 260 samples from Qing Li Peptide across 13 products.
Finnrick Vendor Profile
to
Qing Li Peptide
Tracking 13 products
260 total samples tested
Last test 7 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| PT-141 | 4 | 31 Jul 2025 | 29 Dec 2025 | |||||
| Survodutide | 3 | 14 Jul 2025 | 3 Oct 2025 | |||||
| CJC-1295 | 14 | 10 Jun 2025 | 7 Mar 2026 | |||||
| Cagrilintide | 3 | 9 Jul 2025 | 11 Dec 2025 | |||||
| GHK-Cu | 27 | 10 Jul 2025 | 4 Mar 2026 | |||||
| Melanotan II | 6 | 18 Jul 2025 | 9 Feb 2026 | |||||
| Sermorelin | 5 | 18 Sep 2025 | 30 Dec 2025 | |||||
| BPC-157 | 25 | 11 Jun 2025 | 4 Feb 2026 | |||||
| Ipamorelin | 12 | 10 Jun 2025 | 7 Mar 2026 | |||||
| Retatrutide | 96 | 9 Jun 2025 | 1 Mar 2026 | |||||
| TB-500 | 13 | 29 Jun 2025 | 4 Feb 2026 | |||||
| Tesamorelin | 16 | 29 Jun 2025 | 20 Feb 2026 | |||||
| Tirzepatide | 36 | 3 Jul 2025 | 20 Feb 2026 | |||||
Most recent Qing Li Peptide tests
Samples are tested in commercial labs
260
tests
13
products
Scores
AVGMINMAX
First
9 Jun 2025
Last
7 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Variant | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 7 Mar 2026 | CJC-1295 | View | NO DAC | 5mg | 4.3mg | -14.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 7 Mar 2026 | Ipamorelin | View | 5mg | 4.9mg | -2.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab G | Public | ||
| 4 Mar 2026 | GHK-Cu | View | 50mg | 48.5mg | -3.0% | 99.70% | Jan 6, 2026 | No Label / Silver Crimp / Blue Cap | Lab G | Public | ||
| 1 Mar 2026 | Retatrutide | View | 20mg | 17.7mg | -11.5% | 99.60% | Jan 17, 2026 | No Label / Copper Crimp / Clear Cap | Lab G | Public | ||
| 22 Feb 2026 | Retatrutide | View | 20mg | 27.6mg | +38.0% | 99.22% | 19Sept25-SS65 | White Label / Silver Crimp / Blue Cap | Lab E | Public | ||
| 20 Feb 2026 | Tesamorelin | View | 5mg | 9.83mg | +96.6% | 99.90% | 26/8/25-SS70 | White Label / Silver Crimp / White Cap | Lab E | Public | ||
| 20 Feb 2026 | Tirzepatide | View | 20mg | 22.5mg | +12.5% | 96.14% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | ||
Corrections
- 4 Mar 2026: Retatrutide
- Sample potency on sample fz959qa was incorrectly captured as 0.10 mg, correct quantity was 10 mg.
- 25 Jul 2025:
- Qing Li Peptides print a manufacturing date on their kit boxes. We consider this an equivalent to a batch ID, as it is clearly printed on the packaging and available for the public. When samples are submitted by the public, this identifier was not always collected, affecting test scores. This data may be collected in the future, resulting in an updated test score, and Finnrick Rating.